Beat Bulimia
Concerned Counseling Eating Disorders Site
Peace, Love and Hope
Triumphant Journey
Depression and Eating Disorders

HealthyPlace.com Radio
Eating Disorders Support Groups

Books on Eating Disorders
Conference Transcripts
Eating Disorder Videos
Diaries - Journals
Disorders Definitions
Mental Health News
Online Psychological Tests
Psychiatric Medications
Resources
Site Map

Email
ICQ
Instant Messenger

Visit and Post

Abuse
Addictions
Anxiety-Panic
Depression
Personality Disorders
Self-Injury

send this page to a friend

advertisement

Synthetic Amylin Curbs Tendency to Binge Eating

"The findings of our clinical study further suggest that satiety hormones such as amylin can exert multiple effects on human eating behavior, such as reduced intake of highly-palatable foods and reduced binge eating tendency."

Pramlintide
Pramlintide is the synthetic form of amylin, a satiety hormone produced by the beta cells of the pancreas, which also produce insulin. Pramlintide is marketed in the U.S. by Amylin Pharmaceuticals, under the brand name Symlin, to treat diabetes and control blood sugar. Amylin is one of several hormones secreted when eating and is known to work in partnership with insulin to regulate blood sugar. Pramlintide is also under development as a potential drug for obesity.

(June 8, 2007) -- By American Physiological Society, [RxPG] The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets. The findings on fast food consumption and binge eating tendencies are based on a 6-week research study of 88 obese individuals.

"Satiety hormones are commonly thought to control food intake by signaling to the brain when we are full," said Christian Weyer, M.D., the study's senior author and executive director of clinical research at Amylin Pharmaceuticals, Inc., in San Diego, Calif. "The findings of our clinical study further suggest that satiety hormones such as amylin can exert multiple effects on human eating behavior, such as reduced intake of highly-palatable foods and reduced binge eating tendency."

The study was carried out in 10 U.S. research sites and was reported by Steven R. Smith of the Pennington Biomedical Research Center in Baton Rouge, La.; John E. Blundell of the University of Leeds, United Kingdom; and Colleen Burns, Cinzia Ellero, Brock E. Schroeder, Nicole C. Kesty, Kim Chen, Amy E. Halseth, Cameron W. Lush and Christian Weyer, all of Amylin Pharmaceuticals.

advertisement

Source: American Physiological Society

Last updated: 06/07

Related Information:

back to top | news index | news index for 2006

HealthyPlace.com Eating Disorders Center Links
home ~ site map ~ types ~ causes ~ people ~ treatments ~ self-help
support ~ related conditions ~ impact on relationships ~ news





advertisement


HealthyPlace.com Homepage
Chat ~ Forums ~ Communities
HealthyPlace.com Films ~ HealthyPlace.com Radio ~ News
Site Map ~ Web Tour ~ Advertise ~ Email Us
send this page to a friend

© 2000-2008 HealthyPlace.com, Inc. All rights reserved.
Terms of Use Privacy Policy Disclaimer Advertising Policy